Nutriomics and Artificial Intelligence Nutrition Obesity Cohort

Launched by YONSEI UNIVERSITY · Aug 7, 2022

Keywords

ClinConnect Summary

The Nutriomics and Artificial Intelligence Nutrition Obesity Cohort study is looking to better understand obesity and its related health issues. The trial involves two groups: one group of adults who are obese and have chronic diseases like heart disease or diabetes, and a control group of adults with a healthy weight. Participants will take part in various health checks and tests over five years, including blood tests and examinations for heart and metabolic health. After the fifth year, the focus will shift to following up on any health events.

To be eligible, you need to be at least 19 years old. If you are in the obese group, you should have a Body Mass Index (BMI) of 25 or higher and have a chronic condition. The control group requires a BMI between 18.5 and 24.9. Participants can expect yearly check-ins and possibly phone follow-ups. This study is currently recruiting, and it's important to know that certain health conditions or medications may exclude you from participating.

Gender

ALL

Eligibility criteria

• • Inclusion criteria for the obese group
• • 1. Adults 19 years of age or older
• • 2. Obese patients with chronic diseases such as cardiovascular disease, hypertension, diabetes, and metabolic syndrome (BMI ≥ 25 kg/m2, \[BMI ≥ 30 kg/m2, including 10% or more\])
• • Inclusion criteria for the control group
• • 1. Adults 19 years of age or older
• • 2. Those with BMI 18.5\~24.9 kg/m2
• • Exclusion criteria for the obese group
• • 1. Serious non-cardiovascular disease with life expectancy less than 6 months
• • 2. Pregnant or suspected of being pregnant or are lactating
• • 3. Patients within 3 months of organ transplantation
• • 4. Patients currently being treated for acute transplant rejection
• • 5. Patients treated for acute coronary syndrome (myocardial infarction, unstable angina) and discharged within 6 months
• • 6. Patients with acute cerebral infarction within 6 months of being hospitalized and discharged
• • 7. Type 1 Diabetes
• • 8. Patients taking steroids, female hormones
• • 9. Those who have difficulty using smartphones
• • Exclusion criteria for the control group
• • 1. Serious non-cardiovascular disease with life expectancy less than 6 months
• • 2. Pregnant or suspected of being pregnant or are lactating
• • 3. Persons who are continuously taking medications prescribed by a doctor due to chronic diseases excluding hypertension and dyslipidemia
• • 4. Within 5 years of diagnosis of malignant tumor
• • 5. Those who have difficulty using smartphones